Medscape: HRT Tied to Increased Risk of Severe Asthma Exacerbation
UC allergist discusses hormone replacement therapy’s impact on asthmatic women
Jonathan Bernstein, MD, allergist and professor in the University of Cincinnati College of Medicine, weighs in on a study that suggests hormone replacement therapy may increase the risk of severe asthma in peri- and post-menopausal women.
Researchers say that starting around puberty, asthma becomes more common and severe in women than in men and that continues in women until around menopause. Sex hormones may partly explain the difference.
"It is clear that some women have worsening of a number of health issues peri-menstrual when there are estrogen and/or progesterone surges, including asthma, migraines, urticaria and hereditary angioedema, among other conditions,” Bernstein told a Reuters Health journalist for a story that appeared in Medscape.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.